Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lawrence P Leichman"'
Autor:
Howard P Safran, Kathryn Winter, David H Ilson, Dennis Wigle, Thomas DiPetrillo, Michael G Haddock, Theodore S Hong, Lawrence P Leichman, Lakshmi Rajdev, Murray Resnick, Lisa A Kachnic, Samantha Seaward, Harvey Mamon, Dayssy Alexandra Diaz Pardo, Carryn M Anderson, Xinglei Shen, Anand K Sharma, Alan W Katz, Jonathan Salo, Kara L Leonard, Jennifer Moughan, Christopher H Crane
Publikováno v:
The Lancet. Oncology. 23(2)
Trastuzumab is a monoclonal antibody against HER2 (also known as ERBB2). The primary objective of the NRG Oncology/RTOG-1010 trial was to establish whether trastuzumab improves disease-free survival when combined with trimodality treatment (paclitaxe
Autor:
Daniel, Lin, Heather T, Gold, David, Schreiber, Lawrence P, Leichman, Scott E, Sherman, Daniel J, Becker
Publikováno v:
Cancer. 124(8)
Although outcomes for patients with squamous cell carcinoma of the anus (SCCA) have improved, the gains in benefit may not be shared uniformly among patients of disparate socioeconomic status. In the current study, the authors investigated whether ar
Autor:
Iulia Giuroiu, Geoffrey Yuyat Ku, Lawrence P. Leichman, Kevin Lee Du, Philmo Oh, Benjamin A. Levinson, Syma Iqbal, Charles R. Thomas, Jennifer J. Wu
Publikováno v:
Journal of Clinical Oncology. 36:TPS199-TPS199
TPS199 Background: ESCC comprises 80% of esophageal cancers worldwide. Preoperative chemoRT is a standard-of-care based on the CROSS trial ( N Engl J Med 2012;366:2074-2084), which reported encouraging pathologic complete response (pCR) and overall s
Autor:
Danielle S, Bitterman, David, Grew, Ping, Gu, Richard F, Cohen, Nicholas J, Sanfilippo, Cynthia G, Leichman, Lawrence P, Leichman, Harvey G, Moore, Heather T, Gold, Kevin L, Du
Publikováno v:
Journal of gastrointestinal oncology. 6(5)
To compare clinical and treatment characteristics and outcomes in locally advanced anal cancer, a potentially curable disease, in patients referred from a public or private hospital.We retrospectively reviewed 112 anal cancer patients from a public a
Autor:
Steven J. Tucker, Lawrence P. Leichman
Publikováno v:
Community Oncology. 3:127-129
Autor:
John A. Conti, Franco M. Muggia, Cynthia G. Leichman, R N Susan Jeffers, Lawrence P. Leichman, B A Tara Spiess, Charles W. Young, Leonard B. Saltz
Publikováno v:
Cancer. 75:782-785
Background. UFT is a fixed-ratio combination of uracil and Ftorafur, a prodrug that is absorbed orally and metabolized in vivo to 5-fluorouracil (5-FU). Uracil potentiates 5-FU through interference with its catabolism. The combination of UFT and leuc
Publikováno v:
Current problems in cancer. 14(3)
Although epidermoid cancer of the anus is an uncommon tumor, it has served well as a model for several disciplines within oncology. Advances in understanding the epidemiology and the definitive therapeutic role of combined radiation therapy and chemo